Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. MRK
3. BILL
4. MRNA
5. EL
6. RARE
7. LOW
8. DE
9. ADI
10. COTY

Go back to Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy

Marinus Pharmaceuticals (MRNS) PT Raised to $24.50 at Ladenburg Thalmann

March 6, 2019 1:35 PM EST

Ladenburg Thalmann analyst Michael Higgins raised the price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $24.50 (from $22.00) while maintaining a Buy rating.

... More